$33.45
1.414.40%
At Close: -
$33.45
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Harmony Biosciences
HRMYNASDAQ
Harmony Biosciences (NASDAQ:HRMY) Stock, Earnings Estimates, EPS, And Revenue
Harmony Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 2
EPS Estimate
$0.010
Quarterly Revenue Estimate
$173.5M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$617.5M
Analyze the earnings history of Harmony Biosciences using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HRMY | Harmony Biosciences | $0.76 | $0.01 | — | — | $134.22M | $173.46M | — | — | 08/02/2024 | Get Alert |
| HRMY | Harmony Biosciences | $0.67 | $0.62 | $0.88 | 41.94% | $119.13M | $154.80M | $154.62M | -0.12% | 04/30/2024 | Get Alert |
| HRMY | Harmony Biosciences | $1.01 | $0.48 | $0.73 | 52.08% | $128.31M | $169.06M | $168.41M | -0.38% | 02/22/2024 | Get Alert |
| HRMY | Harmony Biosciences | $0.95 | $0.65 | $0.97 | 49.23% | $117.21M | $148.87M | $160.27M | 7.66% | 10/31/2023 | Get Alert |
| HRMY | Harmony Biosciences | $0.57 | $0.62 | $0.76 | 22.58% | $107.03M | $139.79M | $134.22M | -3.99% | 08/01/2023 | Get Alert |
| HRMY | Harmony Biosciences | $0.51 | $0.47 | $0.66 | 40.43% | $85.31M | $116.79M | $119.13M | 2.00% | 05/02/2023 | Get Alert |
| HRMY | Harmony Biosciences | $0.63 | $0.58 | $1.01 | 74.14% | $91.21M | $127.34M | $128.31M | 0.76% | 02/21/2023 | Get Alert |
| HRMY | Harmony Biosciences | $0.51 | $0.13 | $0.95 | 630.77% | $80.73M | $113.54M | $117.21M | 3.23% | 11/01/2022 | Get Alert |
| HRMY | Harmony Biosciences | $0.54 | $0.44 | $0.57 | 29.55% | $73.82M | $100.75M | $107.03M | 6.23% | 08/02/2022 | Get Alert |
| HRMY | Harmony Biosciences | $0.38 | $0.29 | $0.51 | 75.86% | $59.67M | $88.55M | $85.31M | -3.66% | 05/03/2022 | Get Alert |
| HRMY | Harmony Biosciences | $0.25 | $0.37 | $0.63 | 70.27% | $56.29M | $90.01M | $91.21M | 1.34% | 02/28/2022 | Get Alert |
| HRMY | Harmony Biosciences | -$0.14 | $0.28 | $0.51 | 82.14% | $45.61M | $79.85M | $80.73M | 1.10% | 11/09/2021 | Get Alert |
| HRMY | Harmony Biosciences | — | $0.18 | $0.54 | 200.00% | — | $68.77M | $73.82M | 7.34% | 08/10/2021 | Get Alert |
| HRMY | Harmony Biosciences | — | -$0.03 | $0.38 | 1366.67% | — | $57.07M | $59.67M | 4.56% | 05/11/2021 | Get Alert |
| HRMY | Harmony Biosciences | — | $0.09 | $0.25 | 177.78% | — | $51.85M | $56.29M | 8.56% | 03/25/2021 | Get Alert |
| HRMY | Harmony Biosciences | — | -$0.05 | -$0.14 | -180.00% | — | $40.07M | $45.61M | 13.82% | 11/12/2020 | Get Alert |
Harmony Biosciences (HRMY) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-30 | $0.88 | $0.62 | 41.9 % |
| Dec 2023 | 2024-02-22 | $0.73 | $0.48 | 52.1 % |
| Sep 2023 | 2023-10-31 | $0.97 | $0.65 | 49.2 % |
| Jun 2023 | 2023-08-01 | $0.76 | $0.62 | 22.6 % |
Harmony Biosciences (HRMY) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-30 | $154.62M | $154.80M | -0.12 % |
| Dec 2023 | 2024-02-22 | $168.41M | $169.06M | -0.38 % |
| Sep 2023 | 2023-10-31 | $160.27M | $148.87M | 7.66 % |
| Jun 2023 | 2023-08-01 | $134.22M | $139.79M | -3.99 % |
FAQ
When is Harmony Biosciences (NASDAQ:HRMY) reporting earnings?
Harmony Biosciences (HRMY) is scheduled to report earnings on August 2, 2024. The last reported earnings were for reported on April 30, 2024 for Q1.
What were the latest earnings per share (EPS) for Harmony Biosciences (NASDAQ:HRMY)?
The Actual EPS was $0.88, which beat the estimate of $0.62.
What were Harmony Biosciences’s (NASDAQ:HRMY) revenues?
The Actual Revenue was $154.6M, which missed the estimate of $154.8M.
Browse earnings estimates, EPS, and revenue on all stocks.